Anais de Moura, MD

To explore critical unanswered questions in the radiosurgical management of patients with ≥25 cumulative brain metastases (BMs), specifically: (1) whether dose-volume thresholds to uninvolved brain exist beyond which neurotoxicity becomes unacceptable, (2) wh...